Exchange Traded Concepts LLC Has $6.99 Million Stake in Astera Labs, Inc. $ALAB

Exchange Traded Concepts LLC boosted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 46.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,031 shares of the company’s stock after acquiring an additional 13,415 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Astera Labs were worth $6,992,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Royal Bank of Canada grew its position in shares of Astera Labs by 167.3% in the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after acquiring an additional 95,409 shares during the period. AQR Capital Management LLC raised its holdings in shares of Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after purchasing an additional 7,756 shares during the period. Empowered Funds LLC lifted its stake in Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after purchasing an additional 4,183 shares during the last quarter. Creative Planning lifted its stake in Astera Labs by 37.6% in the 2nd quarter. Creative Planning now owns 13,368 shares of the company’s stock valued at $1,209,000 after purchasing an additional 3,656 shares during the last quarter. Finally, Cetera Investment Advisers grew its holdings in Astera Labs by 167.1% during the second quarter. Cetera Investment Advisers now owns 9,131 shares of the company’s stock worth $826,000 after purchasing an additional 5,712 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Analysts Set New Price Targets

ALAB has been the topic of a number of recent analyst reports. Northland Securities boosted their price target on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Citigroup reduced their target price on Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, February 11th. Loop Capital initiated coverage on Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 target price on the stock. Finally, Morgan Stanley restated an “overweight” rating and issued a $210.00 price target on shares of Astera Labs in a research note on Wednesday, December 3rd. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $202.22.

Insider Activity at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 157,500 shares of the company’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $131.58, for a total value of $20,723,850.00. Following the transaction, the chief executive officer directly owned 4,531,732 shares of the company’s stock, valued at $596,285,296.56. This represents a 3.36% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO Sanjay Gajendra sold 94,971 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the transaction, the chief operating officer owned 1,531,301 shares in the company, valued at $189,590,376.81. The trade was a 5.84% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 384,292 shares of company stock valued at $48,724,919 in the last 90 days. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB opened at $112.47 on Monday. The firm has a market cap of $19.26 billion, a P/E ratio of 92.19, a price-to-earnings-growth ratio of 2.21 and a beta of 1.75. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90. The firm’s 50-day simple moving average is $138.30 and its 200 day simple moving average is $162.90.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. During the same period last year, the business posted $0.37 earnings per share. The business’s revenue for the quarter was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.